PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2C) VERSUS CAPECITABINE ONLY (C-ONLY)
May 1, 2008, 00:00
10.1016/S1098-3015(10)70189-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70189-3/fulltext
Title :
PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2C) VERSUS CAPECITABINE ONLY (C-ONLY)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70189-3&doi=10.1016/S1098-3015(10)70189-3
First page :
Section Title :
Open access? :
No
Section Order :
834